Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway

Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway

Gastric cancer (GC) is one of the most common malignancies and has the second highest lethal rate in the world; thus, finding new medicines with high potency and low toxicity is urgent. Cudrania tricuspidata (Carr.) Bur. ex Lavallee (Moraceae) is a traditional medicinal herb that is considered to ha...

Full description

Bibliographic Details
Main Authors: Jiamei Zhang, Huihui Sun, KunXiu Jiang, Xingzhuo Song, Xirui Wang, Yuqian Yang, Hanying Liu, Qingxuan Ji, Xue Yu, Yonggang Liu, Jing Han, Wei Wang
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Cudraxanthone L
Gastric cancer
MAPK signalling pathway
FAS
Angiogenesis
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221006582

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221006582

Similar Items